Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01970670 · ClinicalTrials.gov registry record
Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 50
- Enrollment target
NCT01970670: Completed study, sponsored by Stanford University.
NCT01970670 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01970670 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The primary objective is to determine how accurately one can estimate the size of the index tumor on preoperative imaging in patients with known breast cancer, using pathology as a reference standard. The primary endpoint, which will be measured on CEDM,and CE-MRI, is the maximum diameter (mm) of the index tumor.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-08-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01970670
The ClinicalTrials.gov registry entry for NCT01970670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01970670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01970670 about?
NCT01970670 is a clinical study titled "Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer". The primary objective is to determine how accurately one can estimate the size of the index tumor on preoperative imaging in patients with known breast cancer, using pathology as a reference standard. The primary endpoint, which will be measured on CEDM,and CE-MRI, is the maximum diameter (mm) of th...
What is the current status of trial NCT01970670?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2015-04. Estimated completion is 2017-08-18.
Who is sponsoring clinical trial NCT01970670?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.